Legionella is a genus of bacteria, with Legionella pneumophila being the most significant species associated with human disease. These bacteria thrive in aquatic environments, including natural water sources and human-made water systems like cooling towers, plumbing systems, and hot tubs. Inhalation of aerosolized water droplets containing Legionella can lead to respiratory infections. Legionnaires' disease is a severe form of pneumonia caused by Legionella infection. The symptoms include high fever, cough, shortness of breath, muscle aches, and headaches. The disease can progress rapidly, leading to respiratory failure and other severe complications, especially in individuals with weakened immune systems or underlying health conditions. Pontiac fever is a milder, non-pneumonic illness caused by Legionella infection. It manifests as a flu-like illness with fever, chills, headache, and muscle aches. Unlike Legionnaires' disease, Pontiac fever does not involve pneumonia, and patients usually recover without specific treatment. Diagnosis of Legionella infections often involves laboratory tests, such as culture, polymerase chain reaction (PCR), and urinary antigen tests. Treatment includes antibiotics like macrolides or fluoroquinolones, with early intervention being crucial for optimal outcomes.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation